Genetron Holdings Limited Rings the Opening Bell in Celebration of its IPO
ABOUT THIS EVENT
Genetron Holdings Limited (Nasdaq: GTH), a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment, rang the Nasdaq Opening Bell virtually from Beijing, China.
In honor of the occasion, Sizhen Wang, CEO, rang the Opening Bell alongside the Company’s team in a virtual bell ringing ceremony.